US › Healthcare

Immutep Ltd ADR (IMMP)

US · Healthcare · Biotechnology

$3.20-0.31%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$10.6M

Revenue YoY

+513.7%

Net profit

$-34.9M

Net margin

-328.8%

Key statistics

Market cap

$26.7M

Forward P/E

7.1

P/B

0.89

Book value

$5.89

EPS (TTM)

$-7.30

52-week high

$66.39

52-week low

$3.55

50-day MA

$6.60

200-day MA

$21.21

Beta

2.30

Analyst view

Analysts rate Immutep Ltd ADR a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Insiders

0.01%

Institutions

1.13%

Largest institutional holders

Fund	Stake
BlackRock Inc	0.50%
JustInvest LLC	0.24%
Marshall Wace Asset Management Ltd	0.06%
Two Sigma Investments LLC	0.05%
Mariner Wealth Advisors LLC	0.05%
XTX Topco Ltd	0.03%
Citigroup Inc	0.03%
Hbk Sorce Advisory LLC	0.03%

Corporate actions

Action	Detail	Date
Split	1 : 20 effective Sep 28, 2026	2026-09-28

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Immutep Ltd ADR — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.